Insights

Genetically Advanced Revivicor is actively developing genetically modified pigs with multiple human gene integrations and specificity around training and production of fully-human polyclonal antibodies, suggesting opportunities to collaborate on biotech production, antibody sources, and therapeutic research partnerships.

Strategic Acquisition Historical ownership by United Therapeutics and ongoing development under Revivicor indicate a track record of strategic partnerships and potential for licensing, co-development, or acquisition discussions with larger biotech or pharma players seeking pig-based biomanufacturing platforms.

Regulatory Ready The focus on GalSafe pigs and human gene integrations points to prior regulatory navigation and quality control frameworks, presenting a sales angle for tools, services, or compliance consulting in biobanking, GMP-grade production, and regulatory documentation support.

Digital & Compliance Stack Adoption of cloud and enterprise tech (AWS, Azure, iCIMS, WordPress, Osano, Imperva) signals a tech-forward operating model; opportunities exist to offer security, data management, cloud optimization, or vendor risk management solutions to support R&D data workflows and collaboration.

Mid-market Focus With a small to mid-size employee base and revenue in the lower end of biotech, Revivicor represents a target for scalable supplier partnerships, contract manufacturing services, and outsourcing vendors that align with growing biotech research and development needs.

Similar companies to Revivicor, Inc.

Revivicor, Inc. Tech Stack

Revivicor, Inc. uses 8 technology products and services including iCIMS, Amazon Web Services, WordPress, and more. Explore Revivicor, Inc.'s tech stack below.

Revivicor, Inc.'s Email Address Formats

Revivicor, Inc. uses at least 1 email format:
Revivicor, Inc. Email FormatsExamplePercentage
FLast@revivicor.comJDoe@revivicor.com
100%

Frequently Asked Questions

What is Revivicor, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Revivicor, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Revivicor, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Revivicor, Inc.'s official website is revivicor.com and has social profiles on LinkedIn.

How much revenue does Revivicor, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Revivicor, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Revivicor, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Revivicor, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Revivicor, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Revivicor, Inc. has approximately 19 employees across 1 continents, including North America. Key team members include Vice President Comm Development: P. R., Senior Research Associate: S. F. B. and Other Information Systems Information Technology Technology Professional: A. W. Explore Revivicor, Inc.'s employee directory with LeadIQ.

What industry does Revivicor, Inc. belong to?

Minus sign iconPlus sign icon
Revivicor, Inc. operates in the Biotechnology Research industry.

What technology does Revivicor, Inc. use?

Minus sign iconPlus sign icon
Revivicor, Inc.'s tech stack includes iCIMS, Amazon Web Services, WordPress, Osano, Adobe Experience Cloud, DocuSign, Microsoft Azure and Imperva.

What is Revivicor, Inc.'s email format?

Minus sign iconPlus sign icon
Revivicor, Inc.'s email format typically follows the pattern of FLast@revivicor.com. Find more Revivicor, Inc. email formats with LeadIQ.
Revivicor, Inc. logo

Revivicor, Inc.

Biotechnology ResearchVirginia, United States11-50 Employees

Revivicor, Inc. operates in the biotechnology research space, focusing on innovations that involve pigs and human genes with the aim of addressing medical needs. Based in Blacksburg, Virginia, the company has a moderate size and concentrates on developing technologies and products relevant to therapeutic development and immune-related applications. Recent activity highlights the company’s work in modifying pigs to express human traits, such as incorporating human genes to reduce complications like blood clotting and inflammation, which illustrates its broader interest in advancing biologically engineered solutions for human health. The organization is part of a broader biotech ecosystem that includes other firms pursuing specialized biologics and antibody technologies.

Historically, Revivicor has been associated with large-scale partnerships and corporate activity within the biotechnology landscape, including its relationship with United Therapeutics Corp. The company operates within the biotechnology research industry, with a focus on translating genetic and cellular approaches into clinically relevant platforms. Its location in Blacksburg situates it within a regional hub for scientific research, while its scope appears oriented toward collaboration with larger entities and potential applications in medical science that rely on genetically modified animal models.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Revivicor, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.